{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T13:59:04Z","timestamp":1774360744615,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Programs of research institutions within Yunnan medical and health Department","award":["2017NS124"],"award-info":[{"award-number":["2017NS124"]}]},{"name":"Applied Basic Research Programs of Science and Technology Department of Yunnan Province","award":["2013FZ217"],"award-info":[{"award-number":["2013FZ217"]}]},{"name":"Key new product development project of Yunnan science and technology","award":["2016BC005"],"award-info":[{"award-number":["2016BC005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12985-018-1112-6","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:32:41Z","timestamp":1546972361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China"],"prefix":"10.1186","volume":"16","author":[{"given":"Jianjian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuixian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingqi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"1112_CR1","doi-asserted-by":"publisher","unstructured":"Broder S. The development of antiretroviral therapy and its impact on the HIV-1\/AIDS pandemic. Antivir Res. 2010;85:1\u201318. https:\/\/doi.org\/10.1016\/j.antiviral.2009.10.002 PMID: 20018391.","DOI":"10.1016\/j.antiviral.2009.10.002"},{"key":"1112_CR2","doi-asserted-by":"publisher","unstructured":"Tsibris AM, Hirsch MS. Antiretroviral therapy in the clinic. J Virol. 2010;84:5458\u201364. https:\/\/doi.org\/10.1128\/JVI.02524-09 PMID: 20181709.","DOI":"10.1128\/JVI.02524-09"},{"key":"1112_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","volume":"376","author":"PA Volberding","year":"2010","unstructured":"Volberding PA, Deeks SG. Antiretroviral therapy and management of HIV infection. Lancet. 2010;376:49\u201362 https:\/\/doi.org\/10.1016\/S0140-6736(10)60676-9 . PMID: 20609987.","journal-title":"Lancet"},{"issue":"5","key":"1112_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.puhe.2011.01.008","volume":"125","author":"KL Zhang","year":"2011","unstructured":"Zhang KL, Zhou JS. Recapturing public health sciences for HIV\/AIDS in China. Public Health. 2011;125(5):266\u20138 https:\/\/doi.org\/10.1016\/j.puhe.2011.01.008 . PMID: 21419465.","journal-title":"Public Health"},{"issue":"1","key":"1112_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/QAI.0b013e318229f2a2","volume":"58","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Mu W, Harwell J, Zhou H, Sun X, Cheng Y, et al. Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China. J Acquir Immune Defic Syndr. 2011;58(1):47\u201353 https:\/\/doi.org\/10.1097\/QAI.0b013e318229f2a2 . PMID: 21725248.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1112_CR6","doi-asserted-by":"publisher","unstructured":"Li JY, Li HP, Li L, Li H, Wang Z, Yang K, et al. Prevalence and evolution of drug resistance HIV-1 variants in Henan. China Cell Res. 2005;15(11\u201312):843\u20139. https:\/\/doi.org\/10.1038\/sj.cr.7290356 PMID: 16354557.","DOI":"10.1038\/sj.cr.7290356"},{"issue":"4","key":"1112_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10461-014-0978-6","volume":"19","author":"L Jose","year":"2015","unstructured":"Jose L. Moreno, Delwyn C, Hyoung S, Lee, Kathy G. the relationship between ART adherence and smoking status among HIV+ individuals. AIDS Behav. 2015;19(4):619\u201325 https:\/\/doi.org\/10.1007\/s10461-014-0978-6 . PMID: 25572828.","journal-title":"AIDS Behav"},{"issue":"1","key":"1112_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.antiviral.2009.09.015","volume":"85","author":"R Paredes","year":"2010","unstructured":"Paredes R, Clotet B. Clinical management of HIV-1 resistance. Antivir Res. 2010;85(1):245\u201365 https:\/\/doi.org\/10.1016\/j.antiviral.2009.09.015 . PMID: 19808056.","journal-title":"Antivir Res"},{"key":"1112_CR9","unstructured":"Luo L, Li TS. Overview of antiretroviral treatment in China: advancement and challenge. Chin Med J.2011(Engl); 124(3): 440\u2013444. PMID: 21362348"},{"key":"1112_CR10","doi-asserted-by":"publisher","unstructured":"Su Q, Liang H, Cen P, Bi Z, Zhou P. HIV type 1 subtypes based on the pol gene and drug resistance mutations among antiretroviralnaive patients from Guangxi, Southern China. AIDS Res Hum Retrovir. 2012;28(7):725\u20138 https:\/\/doi.org\/10.1089\/AID.2011.0246. PMID: 21916807.","DOI":"10.1089\/AID.2011.0246."},{"issue":"9","key":"1112_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1089\/aid.2009.0252","volume":"26","author":"L Ma","year":"2010","unstructured":"Ma L, Huang J, Xing H, Yuan L, Yu X, Sun J, et al. Genotypic and phenotypic cross-drug resistance of harboring drug-resistant HIV type 1 subtype B' strains from former blood donors in central Chinese provinces. AIDS Res Hum Retrovir. 2010;26(9):1007\u201313 https:\/\/doi.org\/10.1089\/aid.2009.0252. PMID: 20718629.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"12","key":"1112_CR12","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1089\/aid.2012.0164","volume":"28","author":"X Wang","year":"2012","unstructured":"Wang X, He C, Xing H, Liao L, Xu X, He J, et al. Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China. AIDS Res Hum Retrovir. 2012;28(12):1637\u20139 https:\/\/doi.org\/10.1089\/AID.2012.0164 . PMID: 22822770.","journal-title":"AIDS Res Hum Retrovir"},{"key":"1112_CR13","doi-asserted-by":"publisher","unstructured":"Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, et al. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China. AIDS Res Hum Retrovir. 2011;27(10):1047\u201353 https:\/\/doi.org\/10.1089\/AID.2010.0119 . PMID: 21417755.","DOI":"10.1089\/AID.2010.0119"},{"key":"1112_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/157016211795569122","volume":"9","author":"X Wang","year":"2011","unstructured":"Wang X, Yang L, Li H, Zuo L, Liang S, Liu W, et al. Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China. Curr HIV Res. 2011;9:103\u201311 PMID: 21361864.","journal-title":"Curr HIV Res"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7326\/0003-4819-151-4-200908180-00006","volume":"151","author":"F Zhang","year":"2009","unstructured":"Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, et al. Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med. 2009;151:241\u201351 PMID: 19687491.","journal-title":"Ann Intern Med"},{"key":"1112_CR16","unstructured":"Chinese Center of Disease and Control. Manual of the national free antiretroviral treatment, 2007."},{"issue":"6","key":"1112_CR17","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.meegid.2011.05.017","volume":"11","author":"L Li","year":"2011","unstructured":"Li L, Lu X, Li H, Chen L, Wang Z, Liu Y, et al. High genetic diversity of HIV-1 was found in men who have sex with men in Shijiazhuang. China Infect Genet Evol. 2011;11(6):1487\u201392 https:\/\/doi.org\/10.1016\/j.meegid.2011.05.017 . PMID: 21645646.","journal-title":"China Infect Genet Evol"},{"issue":"6","key":"1112_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/aid.2010.0026","volume":"26","author":"L Li","year":"2010","unstructured":"Li L, Liang S, Chen L, Liu W, Li H, Liu Y, et al. Genetic characterization of 13 subtype CRF01_AE near full-length genomes in Guangxi. China. AIDS Res Hum Retrovir. 2010;26(6):699\u2013704 https:\/\/doi.org\/10.1089\/aid.2010.0026 . PMID: 20528151.","journal-title":"China. AIDS Res Hum Retrovir."},{"key":"1112_CR19","doi-asserted-by":"publisher","unstructured":"Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4(3):e4724 https:\/\/doi.org\/10.1371\/journal.pone.0004724 . PMID:19266092.","DOI":"10.1371\/journal.pone.0004724"},{"issue":"2","key":"1112_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/QAD.0b013e328011e691","volume":"21","author":"RW Shafer","year":"2007","unstructured":"Shafer RW, Rhee SY, Pillay D, Miller V, Sandstrom P, Schapiro JM, et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS. 2007;21(2):215\u201323 https:\/\/doi.org\/10.1097\/QAD.0b013e328011e691 . PMID:1917 7813.","journal-title":"AIDS"},{"key":"1112_CR21","first-page":"329","volume":"11","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Liu H, Liu C, Wang Z, Ruan Y, Xing H. An analysis of HIV-1 mutations conferring drug resistance in non-responders to highly active antiretroviral therapy (HAART) in Central Henan province. J Pathog Biol. 2016;11:329\u201333.","journal-title":"J Pathog Biol"},{"issue":"6","key":"1112_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/09540121.2011.630359","volume":"24","author":"Y Xing","year":"2012","unstructured":"Xing Y, Sun J, Cao W, Lee L, Guo H, Li H, et al. Economic evaluation of methadone maintenance treatment in HIV\/AIDS control among injecting drug users in Dehong, China. AIDS Care. 2012;24(6):756\u201362 https:\/\/doi.org\/10.1080\/09540121.2011.630359 . PMID: 22149005.","journal-title":"AIDS Care"},{"issue":"6","key":"1112_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7517-10-3","volume":"10","author":"F Yang","year":"2013","unstructured":"Yang F, Lin P, Li Y, He Q, Long Q, Fu X, et al. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm Reduct J. 2013;10(6):3 https:\/\/doi.org\/10.1186\/1477-7517-10-3 . PMID: 23497263.","journal-title":"Harm Reduct J"},{"key":"1112_CR24","doi-asserted-by":"publisher","unstructured":"Xiao L, Wu Z, Luo W, Wei X. Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr Suppl 1. 2010: S116\u2013120. https:\/\/doi.org\/10.1097\/QAI.0b013e3181c7dfb5 . PMID: 20104102","DOI":"10.1097\/QAI.0b013e3181c7dfb5"},{"key":"1112_CR25","doi-asserted-by":"publisher","unstructured":"Mills EJ, Bakanda C, Birungi J, Yaya S, Ford N, et al. The prognostic value of baseline CD4(+) cell count beyond 6 months of antiretroviral therapy in HIV positive individuals in a resource-limited setting. AIDS. 2012;6:1425\u20139 https:\/\/doi.org\/10.1097\/QAD.0b013e328354bf43 . PMID: 22526520.","DOI":"10.1097\/QAD.0b013e328354bf43"},{"issue":"2","key":"1112_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/135965350901400217","volume":"14","author":"M Zaccarelli","year":"2009","unstructured":"Zaccarelli M, Lorenzini P, Ceccherini-Sillberstein F, Tozzi V, Forbici F, Gori C, et al. Historical resistance profile helps to predict salvage failure. Antivir Ther. 2009;14(2):285\u201391 PMID: 19430103 .","journal-title":"Antivir Ther"},{"issue":"3","key":"1112_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/157016212800618129","volume":"10","author":"P Punthiya","year":"2012","unstructured":"Punthiya P, Nareenart I, Wasun C, Sukasem C, Sungkanuparph S. HIV drug resistance interpreted by cumulative versus last Genotypies in HIV-infected patients with multiple Treatmen failures. Current HIV Reasearch. 2012;10(3):271\u20134 PMID: 22497699.","journal-title":"Current HIV Reasearch"},{"issue":"4","key":"1112_CR28","first-page":"132","volume":"23","author":"AM Wensing","year":"2015","unstructured":"Wensing AM, Calvez V, G\u00fcnthard HF, Johnson VA, Paredes R, Pillay D, et al. 2015 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2015;23(4):132\u201341 PMID: 26713503.","journal-title":"Top Antivir Med"},{"issue":"18","key":"1112_CR29","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.1128\/JVI.00618-10","volume":"84","author":"W Jiong","year":"2010","unstructured":"Jiong W, Robert A, Lisa M, Carrie D. Reduced Fitness in Cell Culture of HIV-1 with Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Mutations Correlates with Relative Levels of Reverse Transcriptase Content and RNase H Activity in Virions. J Virol. 2010;84(18):9377\u201389 https:\/\/doi.org\/10.1128\/JVI.00618-10 . PMID: 205920 75.","journal-title":"J Virol"},{"issue":"11","key":"1112_CR30","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1093\/jac\/dkq338","volume":"65","author":"HT Xu","year":"2010","unstructured":"Xu HT, Oliveira M, Quan YJ, Bar-Magen T, Wainberg MA. Differential impact of the HIV-1non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function. J Antimicrob Chemother. 2010;65(11):2291\u20139 https:\/\/doi.org\/10.1093\/jac\/dkq338 . PMID: 20852269.","journal-title":"J Antimicrob Chemother"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-1112-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1112-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T21:58:38Z","timestamp":1662760718000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-1112-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-1112-6","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants provided written National Free Treatment consent, and the study was approved by the Biomedical Ethics Review Committee of Yunnan Province.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"5"}}